TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31744496

Group type: EXPERIMENTAL
Intervention: Apolipoprotein B/A1 ratio
Number of subjects: 2256

Group type: COMPARATOR
Intervention: Framingham Risk Score
Number of subjects: 2256

Group type: COMPARATOR
Intervention: TC/HDL-c
Number of subjects: 2256
Study: 29710336

Group type: EXPERIMENTAL
Intervention: FGF‐23 concentration in the top quartile
Number of subjects: 4947

Group type: EXPERIMENTAL
Intervention: FGF‐23 concentration
Number of subjects: 4947
Study: 27363407

Group type: EXPERIMENTAL
Intervention: Triamcinolone-impregnated nasal dressing
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline-soaked nasal dressing
Number of subjects: 80
Study: 25247897

Group type: EXPERIMENTAL
Intervention: Bupivacaine 0.25% with dexmedetomidine 1 μg/kg (Group I - BD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Bupivacaine 0.25% (Group II - B)
Number of subjects: 40
Study: 22747318

Group type: EXPERIMENTAL
Intervention: Enhanced dissemination strategy (EDS)
Number of subjects: 469

Group type: COMPARATOR
Intervention: Basic dissemination strategy (BDS)
Number of subjects: 469
Study: 19935122

Group type: EXPERIMENTAL
Intervention: Azithromycin 1.5% eye drops, twice daily for 3 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Tobramycin 0.3%, 1 drop every 2 hours for 2 days then 4 times daily for 5 days
Number of subjects: 150
Study: 17687151

Group type: EXPERIMENTAL
Intervention: FOLFOX4 (oxaliplatin + FU/LV)
Number of subjects: 1508

Group type: EXPERIMENTAL
Intervention: Oxaliplatin-containing regimens
Number of subjects: 1508

Group type: COMPARATOR
Intervention: Chemotherapy alone (CR)
Number of subjects: 1508

Group type: COMPARATOR
Intervention: Multimodality approach (CR)
Number of subjects: 1508
Study: 16114087

Group type: EXPERIMENTAL
Intervention: Ginkgo biloba extract
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 12096449

Group type: EXPERIMENTAL
Intervention: Cognitive‐behavioural treatment combined with interventions designed to improve treatment compliance
Number of subjects: 40

Group type: COMPARATOR
Intervention: Cognitive‐behavioural treatment
Number of subjects: 40
Study: 10545734

Group type: EXPERIMENTAL
Intervention: Intrauterine sonography with a 20‐MHz flexible catheter‐based high‐resolution real‐time miniature transducer
Number of subjects: 39

Group type: COMPARATOR
Intervention: Transvaginal sonography
Number of subjects: 39
Study: 7821126

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 14
Study: 2297107

Group type: EXPERIMENTAL
Intervention: Continuous epidural fentanyl infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Continuous intravenous fentanyl infusion
Number of subjects: 20
Study: 772461

Group type: EXPERIMENTAL
Intervention: Baclofen
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 31280470

Group type: EXPERIMENTAL
Intervention: Vitamin D3 70 µg/day
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 28364864

Group type: EXPERIMENTAL
Intervention: Tribulus terrestris (TT)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study: 26525625

Group type: EXPERIMENTAL
Intervention: Cytoflavin
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ethylmethylhydroxypyridine succinate
Number of subjects: 60
Study: 21909736

Group type: EXPERIMENTAL
Intervention: 20 mg enoxaparin
Number of subjects: 3365

Group type: EXPERIMENTAL
Intervention: 40 mg enoxaparin
Number of subjects: 3365

Group type: COMPARATOR
Intervention: 20 mg enoxaparin (in-hospital)
Number of subjects: 3365

Group type: COMPARATOR
Intervention: 40 mg enoxaparin (in-hospital)
Number of subjects: 3365
Study: 21335754

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided technique (UG)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Nerve stimulation technique (NS)
Number of subjects: 12
Study: 19896082

Group type: EXPERIMENTAL
Intervention: G-CSF plus plerixafor
Number of subjects: 298

Group type: COMPARATOR
Intervention: Placebo plus G-CSF
Number of subjects: 298
Study: 17040303

Group type: EXPERIMENTAL
Intervention: Awake removal of LMA (Gp A)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Deep removal of LMA (Gp D)
Number of subjects: 120
Study: 12554339

Group type: EXPERIMENTAL
Intervention: Triangular flap from the anterior sheath of the abdominal rectus muscle
Number of subjects: 91

Group type: COMPARATOR
Intervention: Tension-free hernioplasty with mesh umbrella plug
Number of subjects: 91
Study: 10858984

Group type: EXPERIMENTAL
Intervention: Capsaicin test
Number of subjects: 26

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 26
Study: 9336579

Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Safflower oil
Number of subjects: 0
Study: 8462582

Group type: EXPERIMENTAL
Intervention: Normal orientation of chest radiographs
Number of subjects: 60

Group type: COMPARATOR
Intervention: Rotated orientation of chest radiographs
Number of subjects: 60

Group type: COMPARATOR
Intervention: Unlimited viewing time for rotated images
Number of subjects: 60
Study: 3535053

Group type: EXPERIMENTAL
Intervention: Norfloxacin
Number of subjects: 28

Group type: COMPARATOR
Intervention: Parenteral therapy
Number of subjects: 28
Study: 31891833

Group type: EXPERIMENTAL
Intervention: Low dose of alcohol (mean BAC: 0.03 g/dL) during moped riding simulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sober condition (no alcohol) during moped riding simulation
Number of subjects: 24
Study: 30060256

Group type: EXPERIMENTAL
Intervention: edoxaban
Number of subjects: 1050

Group type: COMPARATOR
Intervention: dalteparin
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: edoxaban (in patients with gastrointestinal cancer)
Number of subjects: 1050

Group type: COMPARATOR
Intervention: dalteparin (in patients with gastrointestinal cancer)
Number of subjects: 1050
Study: 28393633

Group type: EXPERIMENTAL
Intervention: CSP‐1103 (CHF5074)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study: 26266949

Group type: EXPERIMENTAL
Intervention: HPV vaccine awareness and knowledge assessment among teachers
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Recommendation of the HPV vaccine
Number of subjects: 339

Group type: EXPERIMENTAL
Intervention: Barriers to HPV vaccine acceptance
Number of subjects: 339
Study: 23974210

Group type: EXPERIMENTAL
Intervention: 4-hour partial sleep deprivation at the end of the night (SDE)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: 4-hour partial sleep deprivation at the beginning of the night (SDB)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Normal sleep night
Number of subjects: 12
Study: 21080861

Group type: EXPERIMENTAL
Intervention: Telavancin
Number of subjects: 501

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 501
Study: 18420099

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin (10/20 mg/day) + Niacin (titrated to 2 g/day)
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Niacin (titrated to 2 g/day)
Number of subjects: 1220

Group type: COMPARATOR
Intervention: Ezetimibe/Simvastatin (10/20 mg/day)
Number of subjects: 1220
Study: 17063993

Group type: EXPERIMENTAL
Intervention: Icodextrin group (17 patients)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Glucose group (24 patients)
Number of subjects: 41
Study: 12766689

Group type: EXPERIMENTAL
Intervention: Contralateral reinnervation of facial muscles in patients with complete facial palsy
Number of subjects: 15

Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 15
Study: 10837304

Group type: EXPERIMENTAL
Intervention: [57Fe]ferrous fumarate
Number of subjects: 17

Group type: COMPARATOR
Intervention: [57Fe]ferric pyrophosphate
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: [57Fe]ferrous fumarate with 25 mg ascorbic acid
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: [57Fe]ferrous fumarate with 50 mg ascorbic acid
Number of subjects: 17
Study: 9052312

Group type: EXPERIMENTAL
Intervention: 3 micrograms/kg clonidine intravenously
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline or placebo (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Propofol anesthesia
Number of subjects: 60
Study: 8463920

Group type: EXPERIMENTAL
Intervention: Herbal tea preparation
Number of subjects: 68

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 68
Study: 2858214

Group type: EXPERIMENTAL
Intervention: Propranolol (40 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Atenolol (50 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study: 31110087

Group type: EXPERIMENTAL
Intervention: Arthroscopic rotator cuff repair
Number of subjects: 180

Group type: COMPARATOR
Intervention: Placebo surgery (inspection of the shoulder joint)
Number of subjects: 180
Study: 30247579

Group type: EXPERIMENTAL
Intervention: Fluconazole
Number of subjects: 361

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 361

Group type: EXPERIMENTAL
Intervention: Fluconazole and Placebo
Number of subjects: 361
Study: 27899107

Group type: EXPERIMENTAL
Intervention: Unplugged program (12 weekly classes)
Number of subjects: 2185

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 2185
Study: 24557083

Group type: EXPERIMENTAL
Intervention: Nalmefene
Number of subjects: 1276

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1276
Study: 23233798

Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT) for 8 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study: 20416290

Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LM) intervention, n=15
Number of subjects: 30

Group type: COMPARATOR
Intervention: Usual care control, n=15
Number of subjects: 30
Study: 18589473

Group type: COMPARATOR
Intervention: Invisible flicker adaptation
Number of subjects: 0

Group type: COMPARATOR
Intervention: 20Hz flicker
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 5Hz flicker adaptation
Number of subjects: 0
Study: 15657607

Group type: EXPERIMENTAL
Intervention: Information provided to participants in the ABIS Study
Number of subjects: 293

Group type: EXPERIMENTAL
Intervention: Understanding of information regarding high-risk identification, potential prevention, and future questionnaires
Number of subjects: 293
Study: 12098596

Group type: EXPERIMENTAL
Intervention: Iberiotoxin (10-7 M)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nitroglycerin (10-10-10-4 M)
Number of subjects: 0
Study: 11020195

Group type: EXPERIMENTAL
Intervention: Positive early antigen (EA) serology
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Negative EA and viral capsid antigen (VCA) serology
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Negative EA and positive VCA serology
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Serology for EA
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Serology for VCA
Number of subjects: 111
Study: 9049793

Group type: EXPERIMENTAL
Intervention: Resorbable membrane (polyglactin-910)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Non-resorbable membrane (e-PTFE)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Both membrane types
Number of subjects: 11
Study: 8341774

Group type: EXPERIMENTAL
Intervention: Computer-generated telephoned reminders
Number of subjects: 143

Group type: COMPARATOR
Intervention: Control group (no telephoned reminders)
Number of subjects: 143
Study: 3565796

Group type: EXPERIMENTAL
Intervention: Aminophylline (2 mg/kg)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Physiologic saline (5 ml) - Control
Number of subjects: 17
Study: 29800466

Group type: EXPERIMENTAL
Intervention: Dimethyl fumarate (DMF)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study: 26638126

Group type: EXPERIMENTAL
Intervention: Extended Contingent (EC) reinforcement
Number of subjects: 88

Group type: COMPARATOR
Intervention: Extended Noncontingent (EN) reinforcement
Number of subjects: 88
Study: 23982026

Group type: EXPERIMENTAL
Intervention: Light sedation (1.26 ± 0.35 μg/mL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Deep sedation (2.52 ± 0.71 μg/mL)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (regardless of sedation depth)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Pressure support ventilation
Number of subjects: 14
Study: 22771238

Group type: EXPERIMENTAL
Intervention: Org 26576 (100 mg b.i.d.) for 3 weeks
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Org 26576 flexible dose (100-300 mg b.i.d.) for 3 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study: 19995834

Group type: EXPERIMENTAL
Intervention: MS Knowledge Questionnaire (MSKQ)
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Information aid
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Female sex
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Disease duration
Number of subjects: 54
Study: 18345715

Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 95

Group type: COMPARATOR
Intervention: Venlafaxine
Number of subjects: 95
Study: 15910382

Group type: EXPERIMENTAL
Intervention: OKT3 mAbs
Number of subjects: 287

Group type: COMPARATOR
Intervention: Intravenous cyclosporine (CYS)
Number of subjects: 287
Study: 12656538

Group type: EXPERIMENTAL
Intervention: Web-based bedside personal computer
Number of subjects: 8

Group type: COMPARATOR
Intervention: Diagnostic workstation
Number of subjects: 8
Study: 10555907

Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg once daily
Number of subjects: 219

Group type: EXPERIMENTAL
Intervention: Rofecoxib 125 mg once daily
Number of subjects: 219

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study: 9019639

Group type: EXPERIMENTAL
Intervention: quinapril and hydrochlorothiazide (HCTZ)
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: metoprolol and hydrochlorothiazide
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: quinapril and hydrochlorothiazide
Number of subjects: 225

Group type: COMPARATOR
Intervention: quinapril and hydrochlorothiazide and metoprolol and hydrochlorothiazide
Number of subjects: 225
Study: 2063700

Group type: EXPERIMENTAL
Intervention: Tension reduction subscale of the Alcohol Expectancy Questionnaire (AEQ)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate-stress situation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonstress control situation
Number of subjects: 0
Study: 30982298

Group type: EXPERIMENTAL
Intervention: Video with consultation (animated educational video + conventional consultation)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Conventional consultation (without video)
Number of subjects: 0
Study: 28264983

Group type: EXPERIMENTAL
Intervention: Placebo treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 25880964

Group type: EXPERIMENTAL
Intervention: Intervention group (people who inject drugs)
Number of subjects: 2413
Study: 23323566

Group type: EXPERIMENTAL
Intervention: Gastric contraction modulation treatment (TANTALUS-DIAMOND)
Number of subjects: 40
Study: 21253821

Group type: EXPERIMENTAL
Intervention: Families and Schools Together (FAST) program (intervention group, 140 parents)
Number of subjects: 282

Group type: COMPARATOR
Intervention: Control group (142 parents)
Number of subjects: 282
Study: 19579907

Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy (PCIT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waiting-list condition (WL)
Number of subjects: 32
Study: 17551296

Group type: EXPERIMENTAL
Intervention: Sorafenib
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15356042

Group type: EXPERIMENTAL
Intervention: Anastrozole (1 mg) once daily for 6 months
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo once daily for 6 months
Number of subjects: 80
Study: 11430964

Group type: EXPERIMENTAL
Intervention: Intraperitoneal gas drain
Number of subjects: 225

Group type: COMPARATOR
Intervention: Dummy drain (Control)
Number of subjects: 225
Study: 9520555

Group type: EXPERIMENTAL
Intervention: item‐by‐item knowledge of responses
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: answer‐until‐correct
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: delayed feedback
Number of subjects: 73

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 73
Study: 7863489

Group type: EXPERIMENTAL
Intervention: Ascorbic acid (250 mg/kg)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Control (no ascorbic acid)
Number of subjects: 85
Study: 2530191

Group type: EXPERIMENTAL
Intervention: Doxycycline 50 mg daily
Number of subjects: 50

Group type: COMPARATOR
Intervention: Minocycline 100 mg daily (50 mg twice daily)
Number of subjects: 50
Study: 800383

Group type: EXPERIMENTAL
Intervention: Orphenadrine hydrochloride (Disipal)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Tofenacin hydrochloride (Elamol)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluphenazine decanoate therapy
Number of subjects: 0
Study: 31302517

Group type: EXPERIMENTAL
Intervention: Alpha-asymmetry neurofeedback (ALAY)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: High-beta down-training neurofeedback (Beta)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 87
Study: 27054501

Group type: EXPERIMENTAL
Intervention: Worksite stress management training (SMT) intervention
Number of subjects: 153

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 153
Study: 25721186

Group type: EXPERIMENTAL
Intervention: Seaver-NETT (Nonverbal communication, Emotion recognition, and Theory of mind Training)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Facilitated play group (active control)
Number of subjects: 69
Study: 23599941

Group type: EXPERIMENTAL
Intervention: Baseline depression (defined by a CES-D score of 4 or more)
Number of subjects: 2160

Group type: EXPERIMENTAL
Intervention: Baseline depression
Number of subjects: 2160

Group type: EXPERIMENTAL
Intervention: MCI with coexisting depression at baseline
Number of subjects: 2160
Study: 21697501

Group type: EXPERIMENTAL
Intervention: 10 g testosterone gel daily for 6 months
Number of subjects: 209

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 209
Study: 18269306

Group type: EXPERIMENTAL
Intervention: Telephonic disease management (DM)
Number of subjects: 1069
Study: 16545747

Group type: EXPERIMENTAL
Intervention: Verum acupuncture
Number of subjects: 960

Group type: COMPARATOR
Intervention: Sham acupuncture
Number of subjects: 960

Group type: COMPARATOR
Intervention: Standard therapy
Number of subjects: 960
Study: 12631047

Group type: EXPERIMENTAL
Intervention: Propofol 3.5 mg kg(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Thiopentone 5 mg kg(‐1)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol 2 mg kg(‐1)
Number of subjects: 90
Study: 11090727

Group type: EXPERIMENTAL
Intervention: Remifentanil induction (0.5 microg/kg/min) and maintenance (0.25 microg/kg/min)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Fentanyl (maximum of 250 microg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remifentanil
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Remifentanil and Fentanyl
Number of subjects: 75
Study: 9180665

Group type: EXPERIMENTAL
Intervention: Felodipine ER 2.5 mg qd (increased to 5 mg qd after 3 weeks and to 10 mg qd after 6 weeks if SDBP > 90 mm Hg)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 1609548

Group type: EXPERIMENTAL
Intervention: DTP-PRP/D vaccine (109 children)
Number of subjects: 175

Group type: COMPARATOR
Intervention: DTP vaccine (66 children)
Number of subjects: 175
Study: 4027146

Group type: EXPERIMENTAL
Intervention: Nicardipine (5-20 mg three times daily)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Nicardipine and Atenolol combination
Number of subjects: 20
Study: 31972657

Group type: EXPERIMENTAL
Intervention: Remimazolam continuous IV infusion at 5 mg/min for 5 min, 3 mg/min for 15 min, and 1 mg/min for 15 min
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Remimazolam continuous IV infusion
Number of subjects: 20
Study: 29803816

Group type: EXPERIMENTAL
Intervention: In-person group lifestyle intervention
Number of subjects: 211

Group type: EXPERIMENTAL
Intervention: Telephone group lifestyle intervention
Number of subjects: 211

Group type: COMPARATOR
Intervention: Individual medical nutrition therapy (MNT)
Number of subjects: 211
Study: 27684634

Group type: EXPERIMENTAL
Intervention: Self-care program
Number of subjects: 119

Group type: COMPARATOR
Intervention: Usual treatment (Control)
Number of subjects: 119
Study: 25087939

Group type: EXPERIMENTAL
Intervention: Prophylactic polypropylene mesh placement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard abdominal wall closure (nonmesh)
Number of subjects: 0
Study: 22094430

Group type: EXPERIMENTAL
Intervention: Automated interactive telephone system for data collection (75.7% of data collected)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative methods for data provision (personal phone call or post)
Number of subjects: 0
Study: 20418403

Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 1909

Group type: EXPERIMENTAL
Intervention: Beliefs about the influenza vaccine
Number of subjects: 1909
Study: 18041735

Group type: EXPERIMENTAL
Intervention: efavirenz 600 mg daily for 10 days with amprenavir 600 mg twice daily added at day 11
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: efavirenz with dual PIs (nelfinavir, indinavir, ritonavir, saquinavir)
Number of subjects: 55

Group type: COMPARATOR
Intervention: nelfinavir
Number of subjects: 55

Group type: COMPARATOR
Intervention: indinavir
Number of subjects: 55

Group type: COMPARATOR
Intervention: ritonavir
Number of subjects: 55

Group type: COMPARATOR
Intervention: saquinavir
Number of subjects: 55
Study: 16025964

Group type: EXPERIMENTAL
Intervention: Tuihuang decoction rectoclysis (RTD)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Control group (western medicine plus double faced blue treatment)
Number of subjects: 175
Study: 12842378

Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Various combinations of surgery and radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quality of life considerations
Number of subjects: 0
Study: 10799372

Group type: EXPERIMENTAL
Intervention: High-dose BCS (approximately 45 g)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Low-dose BCS (approximately 25 g)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Starch-free placebo
Number of subjects: 38